Global In Vitro Diagnostics Trends in 2022
In Vitro Diagnostics is part of Diagnostics and includes a number of sub-sectors such as In Vitro Diagnostic Reagent. You may also be interested in Laboratory.
Global demand for diagnostic reagents is projected to reach $32.6 billion by 2026, up from $30.1 billion in 2021. This marks a growth of 1.3% year-on-year on average since 2017. The United States was the largest market in terms of diagnostic reagent imports in 2021, with $4.2 billion. Germany, China, and the Netherlands followed as the next biggest markets. Gambia experienced a 69.3% growth year-on-year, while Antigua and Barbuda saw a 6.3% decline since 2017. Global supply of diagnostic reagents is expected to reach $30.8 billion by 2026, increasing 1.4% year-on-year CAGR from the $28.2 billion recorded in 2021. This marks a 4.4% rise since 2016. The US was the leader in exported diagnostic reagents in 2021, with $7.7 billion. Germany, the Netherlands, and the United Kingdom were the next biggest exporters. Burkina Faso saw a 145.8% increase year-on-year, while Mozambique experienced a 66.5% drop since 2016.
Top 10 countries
In 2022 major markets in the In Vitro Diagnostics Industry were:
In Vitro Diagnostics Market Data and Forecasts
How much the In Vitro Diagnostics industry is expected to grow to 2026?
More in In Vitro Diagnostics Industry for 2028Global In Vitro Diagnostics Statistics
- Diagnostic Reagent Import 191 countries (Africa, Asia, Sub-Saharan Africa...)
- Measuring Equipment Import 191 countries (Asia, Africa, Sub-Saharan Africa...)
- Diagnostic Reagent Export 169 countries (Asia, Latin America, Africa...)
- Measuring Equipment Export 176 countries (Asia, Latin America, Africa...)
- Chemical Products Import 192 countries (Asia, Africa, Latin America...)
- Consumer Goods Import 192 countries (Africa, Asia, Sub-Saharan Africa...)
- Chemical Products Export 184 countries (Asia, Latin America, Africa...)
- Pharmaceutical Imports 193 countries (Africa, Asia, Sub-Saharan Africa...)
- Consumer Goods Export 191 countries (Asia, Latin America, Africa...)
- Coke Import 167 countries (Europe, Eastern Europe, Southern Europe...)
Global In Vitro Diagnostics Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Exploring Trends and Strategies in the Global Automated Microbiology Market
The global market for automated microbiology technology, equipment and consumables is experiencing significant growth, largely driven by the increasing demand for advanced diagnostic techniques. New technologies such as next-generation sequencing and high-throughput systems are offering enhanced accuracy, efficiency, and sensitivity in bacterial identification and susceptibility testing. The rise in infectious...
Discover more insights -
Medical Diagnostics: Unveiling Trends in Hemostasis, Virology, and Bacteriology Testing
The hemostasis diagnostics market segment has experienced steady growth due to the increasing prevalence of conditions causing prolonged bleeding disorders such as hemophilia and Von Willebrand Disease (VWD). Despite facing challenges in terms of high costs and complex procedures, advancements in automation and growing demands for precise results have encouraged...
Discover more insights -
Hematology and Flow Cytometry Markets: Unraveling Cutting-edge Technologies and Strategic Competitions
The medical diagnostic sector has witnessed remarkable progress by leveraging advancements in hematology and flow cytometry technology. Research continues to expand, fostering better, more precise systems, which could yield valuable insights into blood and immune disorders. Novel markers and probes utilized in flow cytometry have enhanced our understanding of cellular...
Discover more insights -
Immunodiagnostics: Unveiling Opportunities and Strategies in Therapeutic Drug Monitoring and Tumor Markers Sectors
Both therapeutic drug monitoring (TDM) and tumor markers form integral parts of the burgeoning immunodiagnostics domain. TDM's main function is to regulate drug dosage levels to achieve optimum therapeutic effect with minimal toxicity. Tumor markers, on the other hand, are biological substances indicative of the presence of cancer cells in...
Discover more insights -
Hospital Microbiology Testing: Uncovering Growth Strategies and Opportunities
The realm of clinical microbiology in Germany has seen significant advancements in recent years. The adoption of automated systems has bolstered laboratory efficiency and diagnostics accuracy, reducing turnaround times for infection detection. An emphasis on multidrug resistance testing due to heightened global concerns has also propelled innovations in this segment,...
Discover more insights